These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24206020)

  • 21. [1/2 The anti-TNF alpha drugs].
    Medjoub M; Limat S; Woronoff-Lemsi MC
    Soins; 2007 Oct; (719):59-61. PubMed ID: 18020248
    [No Abstract]   [Full Text] [Related]  

  • 22. Tuberculosis and Legionella pneumophila pneumonia in a patient receiving anti-tumour necrosis factor-alpha (anti-TNF-alpha) treatment.
    Mancini G; Erario L; Gianfreda R; Oliva A; Massetti AP; Mastroianni CM; Vullo V
    Clin Microbiol Infect; 2007 Oct; 13(10):1036-7. PubMed ID: 17711485
    [No Abstract]   [Full Text] [Related]  

  • 23. T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.
    Deepak P; Sifuentes H; Sherid M; Stobaugh D; Sadozai Y; Ehrenpreis ED
    Am J Gastroenterol; 2013 Jan; 108(1):99-105. PubMed ID: 23032984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Update upon efficacy and safety of TNF-α inhibitors.
    Murdaca G; Colombo BM; Cagnati P; Gulli R; Spanò F; Puppo F
    Expert Opin Drug Saf; 2012 Jan; 11(1):1-5. PubMed ID: 22010813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumour necrosis factor-α antagonists in patients with concurrent psoriasis and hepatitis B or hepatitis C: a retrospective analysis of 17 patients.
    Prignano F; Ricceri F; Pescitelli L; Zanieri F; Lotti T
    Br J Dermatol; 2011 Mar; 164(3):645-7. PubMed ID: 21375517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infections associated with tumor necrosis factor-alpha antagonists.
    Rychly DJ; DiPiro JT
    Pharmacotherapy; 2005 Sep; 25(9):1181-92. PubMed ID: 16164393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety of anti-TNF agents during pregnancy and breastfeeding in women with inflammatory bowel disease.
    Gisbert JP; Chaparro M
    Am J Gastroenterol; 2013 Sep; 108(9):1426-38. PubMed ID: 23752881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A review of the evidence for occupational exposure risks to novel anticancer agents - A focus on monoclonal antibodies.
    King J; Alexander M; Byrne J; MacMillan K; Mollo A; Kirsa S; Green M
    J Oncol Pharm Pract; 2016 Feb; 22(1):121-34. PubMed ID: 25227230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Broad range of adverse cutaneous eruptions in patients on TNF-alpha antagonists.
    Hawryluk EB; Linskey KR; Duncan LM; Nazarian RM
    J Cutan Pathol; 2012 May; 39(5):481-92. PubMed ID: 22515220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serious infections in patients with inflammatory bowel disease receiving anti-tumor-necrosis-factor-alpha therapy: an Australian and New Zealand experience.
    Lawrance IC; Radford-Smith GL; Bampton PA; Andrews JM; Tan PK; Croft A; Gearry RB; Florin TH
    J Gastroenterol Hepatol; 2010 Nov; 25(11):1732-8. PubMed ID: 21039834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient outcomes after anti TNF-alpha drugs for Crohn's disease.
    Assasi N; Blackhouse G; Xie F; Marshall JK; Irvine EJ; Gaebel K; Robertson D; Campbell K; Hopkins R; Goeree R
    Expert Rev Pharmacoecon Outcomes Res; 2010 Apr; 10(2):163-75. PubMed ID: 20384563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psoriatic alopecia/alopecia areata-like reactions secondary to anti-tumor necrosis factor-α therapy: a novel cause of noncicatricial alopecia.
    Doyle LA; Sperling LC; Baksh S; Lackey J; Thomas B; Vleugels RA; Qureshi AA; Velazquez EF
    Am J Dermatopathol; 2011 Apr; 33(2):161-6. PubMed ID: 21317611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Practice of universal precautions and risk of occupational blood-borne viral infection among Congolese health care workers.
    Ngatu NR; Phillips EK; Wembonyama OS; Hirota R; Kaunge NJ; Mbutshu LH; Perry J; Yoshikawa T; Jagger J; Suganuma N
    Am J Infect Control; 2012 Feb; 40(1):68-70.e1. PubMed ID: 21592618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Five cases of anti-tumor necrosis factor alpha-induced psoriasis presenting with severe scalp involvement in children.
    Perman MJ; Lovell DJ; Denson LA; Farrell MK; Lucky AW
    Pediatr Dermatol; 2012; 29(4):454-9. PubMed ID: 21995665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The treatment of chronic inflammatory diseases with monoclonal antibodies against tumor necrosis factor: side effects, contraindications and precautions].
    Derksen RH; Bijlsma JW
    Ned Tijdschr Geneeskd; 2002 Jun; 146(25):1165-8. PubMed ID: 12109305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Demyelinating neuropathy during anti-TNF alpha treatment with a review of the literature].
    Hamon MA; Nicolas G; Deviere F; Letournel F; Dubas F
    Rev Neurol (Paris); 2007 Dec; 163(12):1232-5. PubMed ID: 18355471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methotrexate for psoriasiform lesions associated with anti-tumour necrosis factor therapy in inflammatory bowel disease.
    Buisson A; Cuny JF; Barbaud A; Schmutz JL; Bigard MA; Guéant JL; Peyrin-Biroulet L
    Aliment Pharmacol Ther; 2012 May; 35(10):1175-80. PubMed ID: 22469155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions.
    Sfikakis PP
    Curr Dir Autoimmun; 2010; 11():180-210. PubMed ID: 20173395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?
    Askling J; van Vollenhoven RF; Granath F; Raaschou P; Fored CM; Baecklund E; Dackhammar C; Feltelius N; Cöster L; Geborek P; Jacobsson LT; Lindblad S; Rantapää-Dahlqvist S; Saxne T; Klareskog L
    Arthritis Rheum; 2009 Nov; 60(11):3180-9. PubMed ID: 19877027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lepromatous leprosy associated with the use of anti-TNF α therapy: case report.
    Freitas DS; Machado N; Andrigueti FV; Reis Neto ET; Pinheiro MM
    Rev Bras Reumatol; 2010; 50(3):333-9. PubMed ID: 21125169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.